{"date":"2025-03-10","count":47,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6861-2025-03-10-2139-m0j8nf","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-03-10","time":"21:39:17","subject":"更正本公司董事會決議召開民國114年股東常會公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-03-10 21:39，「更正本公司董事會決議召開民國114年股東常會公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-03-10-2034-1ht4b3d","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"20:34:40","subject":"公告本公司董事會決議配合股票初次上市前辦理現金增資發行新股，擬提請原股東全數放棄認購之權利案","clause":"第9款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-03-10 20:34，「公告本公司董事會決議配合股票初次上市前辦理現金增資發行新股，擬提請原股東全數放棄認購之權利案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-03-10-2005-1xjd2jh","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"20:05:29","subject":"本公司董事會決議申請股票上市案","clause":"第44款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-03-10 20:05，「本公司董事會決議申請股票上市案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1907-11wjw0o","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"19:07:00","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 19:07，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-03-10-1843-11wjw0o","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"18:43:24","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-03-10 18:43，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-03-10-1842-1923fmm","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"18:42:04","subject":"公告本公司配合會計師事務所內部調整，自民國114年第1季起更換簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-03-10 18:42，「公告本公司配合會計師事務所內部調整，自民國114年第1季起更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-03-10-1841-1ltnu19","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"18:41:16","subject":"公告本公司113年度財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-03-10 18:41，「公告本公司113年度財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2025-03-10-1839-nob2a5","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"18:39:47","subject":"公告本公司董事會決議盈餘轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2025-03-10 18:39，「公告本公司董事會決議盈餘轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7773-2025-03-10-1811-p67uuk","company_id":"7773","company":"富禾生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"18:11:57","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：富禾生醫（7773），2025-03-10 18:11，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1739-1n8tlux","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"17:39:00","subject":"代重要子公司鼎晉生技股份有限公司公告財務及會計主管異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 17:39，「代重要子公司鼎晉生技股份有限公司公告財務及會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-03-10-1706-1ctgck9","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:06:29","subject":"本公司董事會決議不分派股利","clause":"第31款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-03-10 17:06，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1706-780sz3","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"17:06:24","subject":"代重要子公司鼎晉生技股份有限公司公告商務長辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 17:06，「代重要子公司鼎晉生技股份有限公司公告商務長辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-03-10-1704-pfpud6","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:04:22","subject":"公告本公司董事會決議解除經理人競業禁止限制","clause":"第22款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-03-10 17:04，「公告本公司董事會決議解除經理人競業禁止限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-03-10-1703-100esni","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:03:56","subject":"公告本公司研發主管異動","clause":"第11款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-03-10 17:03，「公告本公司研發主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-03-10-1703-wr0tu2","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:03:40","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-03-10 17:03，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-03-10-1703-drgvb6","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:03:29","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-03-10 17:03，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-03-10-1703-t164yo","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:03:18","subject":"本公司董事會決議召開民國114年股東常會","clause":"第32款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-03-10 17:03，「本公司董事會決議召開民國114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2025-03-10-1702-a3e5jp","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:02:59","subject":"公告本公司董事會決議通過一一三年度合併財務報告","clause":"第43款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2025-03-10 17:02，「公告本公司董事會決議通過一一三年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2025-03-10-1700-6lz62o","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"17:00:53","subject":"公告本公司「經修飾的巨噬細胞、其組成物及其用途」取得南非發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2025-03-10 17:00，「公告本公司「經修飾的巨噬細胞、其組成物及其用途」取得南非發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-03-10-1658-2iz4hx","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"16:58:33","subject":"公告本公司董事會決議不發放股利","clause":"第31款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-03-10 16:58，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1655-13cgfp8","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:55:30","subject":"公告本公司董事會決議辦理現金增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 16:55，「公告本公司董事會決議辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-03-10-1655-1pb8ufa","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"16:55:11","subject":"公告本公司董事會決議召開114年股東常會","clause":"第32款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-03-10 16:55，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-03-10-1653-bwopfv","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:53:51","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-03-10 16:53，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1653-2uoutm","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:53:49","subject":"訂定本公司一一四年度「員工認股權憑證發行及認股辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 16:53，「訂定本公司一一四年度「員工認股權憑證發行及認股辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2025-03-10-1653-1hku5w3","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"16:53:42","subject":"公告本公司董事會通過113年度合併財務報告","clause":"第43款","fact_date":"2025-03-10","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2025-03-10 16:53，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1653-1ezdueo","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:53:12","subject":"訂定本公司一一四年度「限制員工權利新股發行辦法」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 16:53，「訂定本公司一一四年度「限制員工權利新股發行辦法」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1652-1dmdgdo","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:52:33","subject":"公告本公司董事會通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 16:52，「公告本公司董事會通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1647-14vofg8","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:47:02","subject":"公告本公司董事會通過113年度員工酬勞及董事酬勞分配案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 16:47，「公告本公司董事會通過113年度員工酬勞及董事酬勞分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1646-tulf6t","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:46:30","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 16:46，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6637-2025-03-10-1643-1923fmm","company_id":"6637","company":"醫影","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:43:27","subject":"公告本公司配合會計師事務所內部調整，自民國114年第1季起更換簽證會計師","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫影（6637），2025-03-10 16:43，「公告本公司配合會計師事務所內部調整，自民國114年第1季起更換簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-03-10-1636-1pb8ufa","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:36:39","subject":"公告本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-03-10 16:36，「公告本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-03-10-1635-1kmb7k2","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:35:36","subject":"公告本公司董事會決議以私募方式辦理現金增資發行普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-03-10 16:35，「公告本公司董事會決議以私募方式辦理現金增資發行普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-03-10-1633-1hku5w3","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:33:30","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-03-10 16:33，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-03-10-1631-r48478","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:31:53","subject":"公告本公司董事會通過110年現金增資資金運用計畫變更","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-03-10 16:31，「公告本公司董事會通過110年現金增資資金運用計畫變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-03-10-1627-1rgcnj3","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:27:31","subject":"公告本公司為加速LT3001美國三期臨床試驗諮詢進度，董事會決議LT3001-205多劑量二期臨床試驗提前結束收案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-03-10 16:27，「公告本公司為加速LT3001美國三期臨床試驗諮詢進度，董事會決議LT3001-205多劑量二期臨床試驗提前結束收案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-10-1620-1cfzg0q","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:20:04","subject":"本公司授權夥伴Accord Healthcare向歐洲藥品管理局（EMA）提交前列腺癌新劑型新藥 CAMCEVI 3個月劑型新藥上市許可申請（MAA）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-10 16:20，「本公司授權夥伴Accord Healthcare向歐洲藥品管理局（EMA）提交前列腺癌新劑型新藥 CAMCEVI 3個月」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-03-10-1604-w05472","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"16:04:16","subject":"本公司受邀參加德信綜合證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-03-10 16:04，「本公司受邀參加德信綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-03-10-1538-1wain6w","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"15:38:33","subject":"公告本公司113年現金增資收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-03-10 15:38，「公告本公司113年現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-03-10-1537-1nljlpm","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"15:37:50","subject":"公告本公司現金增資董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜(補充公告)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-03-10 15:37，「公告本公司現金增資董事放棄認購股數達得認購股數二分之一以上，並洽特定人認購事宜(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2025-03-10-1532-1j5tdxq","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"15:32:22","subject":"更正本公司113年2月營收及累計營收","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2025-03-10 15:32，「更正本公司113年2月營收及累計營收」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1458-1a7hvqu","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"14:58:04","subject":"公告本公司董事會決議113年度不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 14:58，「公告本公司董事會決議113年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1450-15qvo6g","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"14:50:24","subject":"代重要子公司鼎晉生技股份有限公司公告法人董事改派代表人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 14:50，「代重要子公司鼎晉生技股份有限公司公告法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1449-1czsixm","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"14:49:13","subject":"代重要子公司鼎晉生技股份有限公司公告董事長辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 14:49，「代重要子公司鼎晉生技股份有限公司公告董事長辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1447-938is1","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"14:47:07","subject":"代重要子公司鼎晉生技股份有限公司公告法人董事代表人辭任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 14:47，「代重要子公司鼎晉生技股份有限公司公告法人董事代表人辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1444-1hku5w3","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"14:44:41","subject":"公告本公司董事會通過 113 年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 14:44，「公告本公司董事會通過 113 年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-03-10-1440-1vgpz2i","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-03-10","time":"14:40:40","subject":"公告本公司董事會決議召開民國114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-03-10 14:40，「公告本公司董事會決議召開民國114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-03-10-0604-1mk1k58","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-10","time":"06:04:09","subject":"本公司HLA-G靶向性外泌體(SOB100)通過美國食品藥物管理局(FDA)Phase I 臨床試驗申請(IND)30天審核期","clause":"第44款","fact_date":"2025-03-08","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-03-10 06:04，「本公司HLA-G靶向性外泌體(SOB100)通過美國食品藥物管理局(FDA)Phase I 臨床試驗申請(IND)30天」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}